Molecular genetics suggests the presence of altered polyploid amplification in the region where the TFEB gene is located (6p21 region), including amplification of the critical genes VEGFA and CCND3, suspected to be highly associated with the aggressive clinical course of this tumor in the absence of TFEB gene translocations [5, 6]. The gene discussed is CCND3; the disease is neoplasm.